バーコードによるウイルスの追跡は,免疫抑制性アストロサイトとグリオマの相互作用を特定します
Brian M Andersen1,2, Camilo Faust Akl1,3, Michael A Wheeler1,4,5
1Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nature
|June 25, 2025
まとめ
研究者らは,アネキシンA1-ホルミルペプチド受容体1 (ANXA1-FPR1) によって誘導される,アストロサイトと膠芽細胞 (GBM) の間の通信経路を特定した. この経路は抗腫瘍免疫を抑制し GBM治療の新たな標的となる.
科学分野:
- 神経腫瘍学
- 免疫学
- 携帯電話通信
背景:
- グリオブラストーマ (GBM) は,高度に免疫抑制性の腫瘍微環境 (TME) を有する致命的な脳がんである.
- GBM TME内の免疫調節を理解することは,効果的な免疫療法の開発に不可欠です.
研究 の 目的:
- GBM TME内のセル間通信を単細胞解像度で分析する.
- 免疫回避の新たなメカニズムを 特定する
主な方法:
- 単細胞のTME分析のためにウイルスバーコード相互作用追跡アプローチを使用した.
- 統合された単細胞と大量RNA配列化,オルガノタイプのGBM培養,CRISPR-Cas9遺伝的混乱.
- ヒトとマウスの実験システムを採用した.
主要な成果:
- 双方向のアネキシンA1-ホルミルペプチド受容体1 (ANXA1-FPR1) とアストロサイトとGBM細胞の間の信号伝達経路を特定した.
- ANXA1- FPR1シグナリングは,死滅と炎症反応を抑制することによって,抗腫瘍免疫を抑制することが示されました.
- ANXA1とFPR1の発現が GBM患者の悪い結果と相関していることがわかりました.
- この経路の不活性化により,CD8+ T細胞の浸透を含む抗腫瘍免疫反応が強化された.
結論:
- GBMにおける単細胞TME相互作用分析のための新しい方法を開発した.
- ANXA1-FPR1経路は,免疫回避と腫瘍の進行の主要な原動力である.
- ANXA1-FPR1経路を標的とした治療は GBMの治療の可能性を秘めています
関連する概念動画
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.